Mingyu Qian

2.7k total citations · 1 hit paper
22 papers, 1.8k citations indexed

About

Mingyu Qian is a scholar working on Molecular Biology, Cancer Research and Genetics. According to data from OpenAlex, Mingyu Qian has authored 22 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 14 papers in Cancer Research and 5 papers in Genetics. Recurrent topics in Mingyu Qian's work include Extracellular vesicles in disease (9 papers), MicroRNA in disease regulation (8 papers) and Circular RNAs in diseases (6 papers). Mingyu Qian is often cited by papers focused on Extracellular vesicles in disease (9 papers), MicroRNA in disease regulation (8 papers) and Circular RNAs in diseases (6 papers). Mingyu Qian collaborates with scholars based in China, United States and Norway. Mingyu Qian's co-authors include Hao Xue, Xiao Gao, Shaobo Wang, Zongpu Zhang, Xiaofan Guo, Jianye Xu, Gang Li, Wei Qiu, Zihang Chen and Sue Han and has published in prestigious journals such as Oncogene, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Mingyu Qian

22 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

IDH mutation in glioma: molecular mechanisms and potential therapeutic targets

2020 426 citations Sue Han, Yang Liu et al. British Journal of Cancer profile →

Peers

Countries citing papers authored by Mingyu Qian

Since Specialization

Citations

This map shows the geographic impact of Mingyu Qian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingyu Qian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingyu Qian more than expected).

Fields of papers citing papers by Mingyu Qian

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mingyu Qian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingyu Qian. The network helps show where Mingyu Qian may publish in the future.

Co-authorship network of co-authors of Mingyu Qian

This figure shows the co-authorship network connecting the top 25 collaborators of Mingyu Qian. A scholar is included among the top collaborators of Mingyu Qian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mingyu Qian. Mingyu Qian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	ARPC1B promotes mesenchymal phenotype maintenance and radiotherapy resistance by blocking TRIM21-mediated degradation of IFI16 and HuR in glioma stem cells	Journal of Experimental & Clinical Cancer Research	Zijie Gao, Jianye Xu et al.	34
2	Exosomes derived from hypoxic glioma deliver miR-1246 and miR-10b-5p to normoxic glioma cells to promote migration and invasion	Laboratory Investigation	Mingyu Qian, Zihang Chen et al.	39
3	Exosomal miR-1246 from glioma patient body fluids drives the differentiation and activation of myeloid-derived suppressor cells	Molecular Therapy	Wei Qiu, Xiaofan Guo et al.	90
4	MicroRNA-29a-3p delivery via exosomes derived from engineered human mesenchymal stem cells exerts tumour suppressive effects by inhibiting migration and vasculogenic mimicry in glioma	Aging	Zongpu Zhang, Xing Guo et al.	55
5	Transfer of MicroRNA via Macrophage-Derived Extracellular Vesicles Promotes Proneural-to-Mesenchymal Transition in Glioma Stem Cells	Cancer Immunology Research	Zongpu Zhang, Jianye Xu et al.	74
6	Cullin-7 (CUL7) is overexpressed in glioma cells and promotes tumorigenesis via NF-κB activation	Journal of Experimental & Clinical Cancer Research	Jianye Xu, Zongpu Zhang et al.	45
7	IDH mutation in glioma: molecular mechanisms and potential therapeutic targets breakdown →	British Journal of Cancer	Sue Han, Yang Liu et al.	426
8	Nitidine Chloride Is a Potential Alternative Therapy for Glioma Through Inducing Endoplasmic Reticulum Stress and Alleviating Epithelial-Mesenchymal Transition	Integrative Cancer Therapies	Zihang Chen, Jinsen Zhang et al.	7
9	mTORC2/Rac1 Pathway Predisposes Cancer Aggressiveness in IDH1-Mutated Glioma	Cancers	Yang Liu, Yanxin Lu et al.	18
10	Hypoxia-induced lncRNA PDIA3P1 promotes mesenchymal transition via sponging of miR-124-3p in glioma	Cell Death and Disease	Shaobo Wang, Yanhua Qi et al.	41
11	Exosomes derived from mesenchymal stem cells attenuate the progression of atherosclerosis in ApoE−/- mice via miR-let7 mediated infiltration and polarization of M2 macrophage	Biochemical and Biophysical Research Communications	Jiangbing Li, Hao Xue et al.	174
12	Hypoxic glioma-derived exosomes deliver microRNA-1246 to induce M2 macrophage polarization by targeting TERF2IP via the STAT3 and NF-κB pathways	Oncogene	Mingyu Qian, Shaobo Wang et al.	265
13	<p>GALE Promotes the Proliferation and Migration of Glioblastoma Cells and Is Regulated by miR-let-7i-5p</p>	Cancer Management and Research	Hao Xue, Ye Xiong et al.	16
14	TGFβ1‐induced beta‐site APP‐cleaving enzyme 2 upregulation promotes tumorigenesis through the NF‐κB signalling pathway in human gliomas	Molecular Oncology	Huizhi Wang, Zihang Chen et al.	18
15	PLEKHG5 is a novel prognostic biomarker in glioma patients	International Journal of Clinical Oncology	Mingyu Qian, Zihang Chen et al.	14
16	Immunosuppressive effects of hypoxia-induced glioma exosomes through myeloid-derived suppressor cells via the miR-10a/Rora and miR-21/Pten Pathways	Oncogene	Xiaofan Guo, Wei Qiu et al.	238
17	Glioma exosomes mediate the expansion and function of myeloid‐derived suppressor cells through microRNA‐29a/Hbp1 and microRNA‐92a/Prkar1a pathways	International Journal of Cancer	Xiaofan Guo, Wei Qiu et al.	133
18	lncTCF7 is a negative prognostic factor, and knockdown of lncTCF7 inhibits migration, proliferation and tumorigenicity in glioma	Scientific Reports	Xiao Gao, Xing Guo et al.	11
19	Cytoprotective effect of melatonin against hypoxia/serum deprivation-induced cell death of bone marrow mesenchymal stem cells in vitro	European Journal of Pharmacology	Fuwu Wang, Huaiyu Zhou et al.	45
20	Microarray Gene Expression Profiling of Angiogenesis Inhibitors Using the Rat Aortic Ring Assay	BioTechniques	Theresa G. Zogakis, Nick G. Costouros et al.	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact